Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Dizal Pharmaceutical logo — company profile

Dizal Pharmaceutical

Founded 2017 China Shanghai, China 108 employees Series Unknown Biotechnology, Pharmaceutical

General Information

Company Name Dizal Pharmaceutical
Founded Year 2017
Location China Shanghai, China +2
Employees 108
Industries Biotechnology, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when Dizal Pharmaceutical moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Dizal Pharmaceutical

Dizal Pharmaceutical is a commercial stage biopharmaceutical company based in China. Established in 2017, the company focuses on the discovery and development of therapeutics for cancer and immunological diseases. Leveraging its expertise in translational science and molecular design, Dizal has built a portfolio of five clinical-stage assets, with two leading assets in global pivotal studies and one already approved. As a venture capital, it's worth monitoring Dizal Pharmaceutical for its potential in the biotechnology and pharmaceutical industries.

No funding data available for Dizal Pharmaceutical yet.

Get notified when Dizal Pharmaceutical raises funding

Dizal Pharmaceutical Alternatives & Competitors

Dizal Pharmaceutical vs
Intezyne Technologies
Intezyne Technologies United States

Intezyne is a clinical-stage biotechnology company focused on increasing the effectiveness of cancer...

Series A
4 employees
Biotechnology, Health Care
Compare Dizal Pharmaceutical vs Intezyne Technologies
Dizal Pharmaceutical vs
Q BioMed, Inc
Q BioMed, Inc United States

Q BioMed acquires, develops and finances innovative and undervalued biotechnologies

Post Ipo Equity
2 employees
Biopharma, Biotechnology
Compare Dizal Pharmaceutical vs Q BioMed, Inc
Dizal Pharmaceutical vs
Orenda, Inc
Orenda, Inc United States

Developing and operating energy storage projects.

Seed
34 employees
Energy, Renewable Energy
Compare Dizal Pharmaceutical vs Orenda, Inc

FAQ About Dizal Pharmaceutical

Dizal Pharmaceutical Co., Ltd (Ticker: 688192 ) is a commercial stage biopharmaceutical company. At Dizal we aspire to discover and develop differentiated therapeutics for the treatment of cancer and immunological diseases. Building on our extensive expertise in translational science and molecular d...
Dizal Pharmaceutical was founded in 2017.
Dizal Pharmaceutical is headquartered in Shanghai, China.
Dizal Pharmaceutical operates in the following industries: Biotechnology, Pharmaceutical.
Dizal Pharmaceutical has approximately 108 employees.
Top alternatives and competitors to Dizal Pharmaceutical include Intezyne Technologies, Q BioMed, Inc, Orenda, Inc, Radian Generation, Seelos Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Dizal Pharmaceutical and Intezyne Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Dizal Pharmaceutical and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes